OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart announced today that several clients and AJ Peterson, vice president and general manager, will be presenting...
Renowned Clinic in Washington State Leverages NextGen Enterprise to Provide Affordable Primary Healthcare Services to Residents Who Face Barriers to...
MIAMI--(BUSINESS WIRE)--MSP Recovery, LLC (“MSP” or “MSP Recovery”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader today announced...
Untapped AI identifies post-pandemic ‘business after effects’ as a third of people using its platform declare low mood has increased...
STOCKHOLM, SE / ACCESSWIRE / October 11, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner Roche received...
HAMBURG, GERMANY / ACCESSWIRE / October 11, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today...
GOLDEN, CO / ACCESSWIRE / October 10, 2021 / Vitro Biopharma, Inc. dba Vitro Biopharma, announced its 3rd quarter, ended...
-- Company maintains focus on advancing ADVM-022 at low doses in patients with wet AMD -- Marked Differences in Intraocular...
Kaplan-Meier Survival: RETHYMIC Clinical Program (Efficacy Analysis Set) and Natural History Population Kaplan-Meier Survival: RETHYMIC Clinical Program (Efficacy Analysis Set)...
NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics...
LOS ANGELES, Oct. 08, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that...
CAMBRIDGE, Mass. and NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
BURNABY, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced...
Immediate Release – October 8th, 2021 Louvain-la-Neuve, Belgium, October 8th, 2021 - In accordance with article 8:4 of the Royal...
Six Towers Completed with a value of $350,000VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP....
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD)Gantenerumab is the first and only anti-amyloid...
Improved rating demonstrates Clover’s ability to deliver high-quality healthcare to Medicare eligibles on a wide, open networkNASHVILLE, Tenn., Oct. 08,...
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered...